World's Best Scientists 2026 revealed!
Ulf Müller-Ladner

Ulf Müller-Ladner

D-Index & Metrics

Medicine

D-Index
105
Citations
50254
World Ranking
6692
National Ranking
383

Overview

Ulf Müller-Ladner is affiliated with the University of Giessen in Germany and has published extensively within the field of medicine, focusing primarily on rheumatology. Their scholarly output includes over 410 publications, with significant contributions to subfields such as rheumatology, pathology and forensic medicine, immunology, epidemiology, and dermatology.

The researcher's main areas of focus span several key topics related to systemic autoimmune and inflammatory disorders. These include:

  • Systemic Sclerosis and Related Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Dermatologic Treatments and Research
  • Systemic Lupus Erythematosus Research
  • Inflammatory Myopathies and Dermatomyositis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Frequent publication venues for Müller-Ladner's work are notable for their focus on rheumatic diseases and related biomedical research. These include:

  • Annals of the Rheumatic Diseases
  • Zeitschrift für Rheumatologie
  • Lara D. Veeken
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Clinical and Experimental Rheumatology

Among recent papers, notable titles include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update, 2020, Annals of the Rheumatic Diseases
  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis, 2020, Autoimmunity Reviews
  • Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry, 2021, Annals of the Rheumatic Diseases
  • ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease, 2023, Journal of Crohn's and Colitis

The researcher frequently collaborates with several co-authors, including:

  • Philipp Klemm
  • Elena Neumann
  • Rebecca Hasseli
  • Uwe Lange
  • Klaus Frommer

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Anthony J. Tyndall;Bettina Bannert;Madelon Vonk;Paolo Airò

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

    U A Walker;A Tyndall;L Czirják;C Denton

  • Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

    J Gerry Coghlan;Christopher P Denton;Ekkehard Grünig;Diana Bonderman

  • EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

    O. Kowal-Bielecka;R. Landewé;J. Avouac;S. Chwiesko

  • A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.

    Dae Hyun Yoo;Pawel Hrycaj;Pedro Miranda;Edgar Ramiterre

  • 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    Victoria Furer;Victoria Furer;Christien Rondaan;Marloes W. Heijstek;Nancy Agmon-Levin;Nancy Agmon-Levin

  • EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    S van Assen;N Agmon-Levin;O Elkayam;R Cervera

  • Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    Dinesh Khanna;Christopher P Denton;Angelika Jahreis;Jacob M van Laar

  • Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

    Stephanie Lefèvre;Anette Knedla;Christoph Tennie;Andreas Kampmann

  • Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

    K Visser;W Katchamart;E Loza;J A Martinez-Lopez

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis.

    Thomas Pap;Ulf Müller-Ladner

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri

  • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Suzana Jordan;Jörg H W Distler;Britta Maurer;Dörte Huscher

  • Rheumatoid arthritis progression mediated by activated synovial fibroblasts

    Elena Neumann;Stephanie Lefèvre;Birgit Zimmermann

  • Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis

    Ulf Müller-Ladner;Thomas Pap;Michel Neidhart

  • Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    Florian M P Meier;Klaus W Frommer;Robert Dinser;Ulrich A Walker

Frequent Co-Authors

Oliver Distler
Oliver Distler University of Zurich
Christopher P. Denton
Christopher P. Denton University College London
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Yannick Allanore
Yannick Allanore Université Paris Cité
Gabriela Riemekasten
Gabriela Riemekasten University of Lübeck
Georg Schett
Georg Schett University of Erlangen-Nuremberg
Maurizio Cutolo
Maurizio Cutolo University of Genoa
Valeria Riccieri
Valeria Riccieri Sapienza University of Rome
Jörg H W Distler
Jörg H W Distler University of Erlangen-Nuremberg
Janet E. Pope
Janet E. Pope University of Western Ontario

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medicine but looking for flexible or alternative paths? Online degrees offer diverse opportunities in healthcare and related fields. For those passionate about nutrition and wellness, pursuing an online bachelor's in nutrition can prepare you for roles in dietetics, wellness coaching, and public health education.

Leadership roles in hospitals and health organizations are also in demand. Advancing with a management focus is possible through the top cahme accredited mha programs, which provide quality online education in healthcare administration accredited by the Commission on Accreditation of Healthcare Management Education.

Already a registered nurse? Moving forward in your nursing career is more convenient than ever. Consider an rn to bsn without clinicals program to earn your bachelor’s degree online without additional hands-on requirements.

Aspiring for the highest level in nursing? If you already hold a master’s degree, the shortest msn to dnp program options can fast-track your studies toward a Doctor of Nursing Practice, further opening doors in advanced patient care, research, and leadership.

Best Scientists Citing Ulf Müller-Ladner

Trending Scientists

Recently Published Articles